Showing results (1521-1530 of 1,599) with videos related to

Sort By:
Pageof 160
Scientific Reports|August 3, 2022
MicroRNA-101a enhances trabecular bone accrual in male miceAmel Dudakovic, Sofia Jerez, Padmini J Deosthale, et al.
NPJ Breast Cancer|January 14, 2022
The breast pre-cancer atlas illustrates the molecular and micro-environmental diversity of ductal carcinoma in situDaniela Nachmanson, Adam Officer, Hidetoshi Mori, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1996
In vivo purging with high-dose cytarabine followed by high-dose chemoradiotherapy and reinfusion of unpurged bone marrow for adult acute myelogenous leukemia in first complete remissionA S Stein, M R O'Donnell, A Chai, et al.
The New England Journal of Medicine|April 25, 2019
Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell NeoplasmNaveen Pemmaraju, Andrew A Lane, Kendra L Sweet, et al.
Journal of Cellular Physiology|December 6, 2018
RUNX1-dependent mechanisms in biological control and dysregulation in cancerDeli Hong, Andrew J Fritz, Jonathan A Gordon, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|August 9, 2016
Clinical disposition, metabolism and in vitro drug-drug interaction properties of omadacyclineJimmy Flarakos, Yancy Du, Helen Gu, et al.
Blood Advances|January 10, 2019
MIPSS70+ v2.0 predicts long-term survival in myelofibrosis after allogeneic HCT with the Flu/Mel conditioning regimenHaris Ali, Ibrahim Aldoss, Dongyun Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 11, 2009
The histone gene activator HINFP is a nonredundant cyclin E/CDK2 effector during early embryonic cell cyclesRonglin Xie, Ricardo Medina, Ying Zhang, et al.
Leukemia & Lymphoma|October 8, 1999
Protracted results of dose-intensive therapy using cyclophosphamide, carmustine, and continuous infusion etoposide with autologous stem cell support in patients with relapse or refractory Hodgkin's disease: a phase II study from the North American Marrow Transplant GroupD R Fleming, S N Wolff, J W Fay, et al.
The Journal of Biological Chemistry|October 21, 2016
Enhancer of Zeste Homolog 2 Inhibition Stimulates Bone Formation and Mitigates Bone Loss Caused by Ovariectomy in Skeletally Mature MiceAmel Dudakovic, Emily T Camilleri, Scott M Riester, et al.
Pageof 160